Fecal microbiota transplantation in treating Clostridium difficile infection
- PMID: 24825534
- DOI: 10.1111/1751-2980.12160
Fecal microbiota transplantation in treating Clostridium difficile infection
Abstract
Clostridium difficile infection (CDI) is an increasingly common and severe international health problem. Customary treatment of this infection, usually with antibiotics, is often ineffective and its recurrence is common. In recent years the treatment of recurrent or refractory CDI by the transfer of stool from an uninfected person, so called fecal "microbiota transplantation" has become recognized as effective and generally safe. The effectiveness of this novel treatment is incompletely defined but is likely to be due to its correction of the intestinal dysbiosis that characterizes the disease. Practical methods for the administration of the transplantation have been described. This review summarizes the current reported experiences with fecal microbiota transplantation in the treatment for CDI.
Keywords: Clostridium difficile; dysbiosis; fecal enema; fecal microbiota transplantation; pseudomembranous enterocolitis.
© 2014 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.
Similar articles
-
Fecal microbiota transplantation in the treatment of Clostridium difficile infections.Am J Med. 2014 Jun;127(6):479-83. doi: 10.1016/j.amjmed.2014.02.017. Epub 2014 Feb 26. Am J Med. 2014. PMID: 24582877 Review.
-
Fecal microbiota transplantation and donor standardization.Trends Microbiol. 2013 Sep;21(9):443-5. doi: 10.1016/j.tim.2013.07.003. Trends Microbiol. 2013. PMID: 24012274
-
Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers.Curr Opin Gastroenterol. 2014 Jan;30(1):47-53. doi: 10.1097/MOG.0000000000000023. Curr Opin Gastroenterol. 2014. PMID: 24275671 Review.
-
Treatment of recurrent and severe Clostridium difficile infection.Annu Rev Med. 2015;66:373-86. doi: 10.1146/annurev-med-070813-114317. Annu Rev Med. 2015. PMID: 25587656 Review.
-
Fecal microbiota transplantation for recurrent clostridium difficile infection.J Clin Gastroenterol. 2011 Nov;45 Suppl:S159-67. doi: 10.1097/MCG.0b013e318222e603. J Clin Gastroenterol. 2011. PMID: 21992957 Review.
Cited by
-
Revealing the secret life of skin - with the microbiome you never walk alone.Int J Cosmet Sci. 2020 Apr;42(2):116-126. doi: 10.1111/ics.12594. Epub 2019 Dec 25. Int J Cosmet Sci. 2020. PMID: 31743445 Free PMC article. Review.
-
Gut Microbiota as a Therapeutic Target to Ameliorate the Biochemical, Neuroanatomical, and Behavioral Effects of Traumatic Brain Injuries.Front Neurol. 2019 Aug 16;10:875. doi: 10.3389/fneur.2019.00875. eCollection 2019. Front Neurol. 2019. PMID: 31474930 Free PMC article. Review.
-
Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation.J Immunol Res. 2019 Apr 16;2019:1603758. doi: 10.1155/2019/1603758. eCollection 2019. J Immunol Res. 2019. PMID: 31143780 Free PMC article. Review.
-
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.Dig Dis Sci. 2017 May;62(5):1131-1145. doi: 10.1007/s10620-017-4535-9. Epub 2017 Mar 17. Dig Dis Sci. 2017. PMID: 28315032 Review.
-
Harnessing the Power of Defensive Microbes: Evolutionary Implications in Nature and Disease Control.PLoS Pathog. 2016 Apr 8;12(4):e1005465. doi: 10.1371/journal.ppat.1005465. eCollection 2016 Apr. PLoS Pathog. 2016. PMID: 27058881 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
